(Reuters) - The U.S. Food and Drug Administration approved Lundbeck's antidepressant Brintellix to treat adults with major depressive disorder. The drug, which Lundbeck will co-market with Japanese partner Takeda Pharmaceutical Co Ltd, will be...
Source: http://health.yahoo.net/news/s/nm/fda-approves-lundbeck-s-antidepressant-brintellix
homepage here site here website here citation
No comments:
Post a Comment
Note: only a member of this blog may post a comment.